Form 8.3 - Balanced Commercial Property Trust Limited
May 21, 2024 09:16 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Verisk Analytics, Inc. Announces Tender Offer for up to $400 million Principal Amount of Outstanding Debt
May 21, 2024 09:16 ET
|
Verisk Analytics, Inc.
JERSEY CITY, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Verisk Analytics, Inc. (Nasdaq: VRSK) (“Verisk” or the “Company”), a leading global data analytics and technology provider, today announced that...
Invesco Ltd: Form 8.3 - Keywords Studios PLC_OPD
May 21, 2024 09:15 ET
|
Invesco Ltd.
FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
Invidia Capital Management Announces Healthcare Investment Firm Launch with Strategic Investment from GCM Grosvenor
May 21, 2024 09:15 ET
|
GCM Grosvenor
NEW YORK and CHICAGO, May 21, 2024 (GLOBE NEWSWIRE) -- Invidia Capital Management, a healthcare investment firm founded by former Goldman Sachs partner Jo Natauri, has announced its launch with a...
Verusen Expands into Exciting New Vertical Markets Globally; Appoints MRO Industry Veteran Jeremiah Woodford as CRO; Broadens Executive Sales Leadership With Additional New Hires
May 21, 2024 09:15 ET
|
Verusen
Verusen announces new sales and revenue leadership and global vertical market expansion into Oil & Gas, Mining, and Power Generation & Utilities.
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
May 21, 2024 09:15 ET
|
GT Biopharma, Inc.
BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), today announced that it has entered into a definitive securities purchase agreements for the...
Form 8.3 - Abrdn European Logistics Income Plc
May 21, 2024 09:14 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
May 21, 2024 09:14 ET
|
Lyra Therapeutics
WATERTOWN, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced that it is advancing its goal to preserve capital by implementing...
Epigenetics Market Size, Share & Trends Analysis Report 2024-2030
May 21, 2024 09:12 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments), By Technology (DNA Methylation), By Application...
HydroGraph and Gulf Cryo Begin Initial Steps to Bring Pristine Graphene to the Middle East
May 21, 2024 09:11 ET
|
Hydrograph Clean Power Inc.
VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”), a commercial manufacturer of pristine graphene,...